Pericardium, epicardial adipose tissue, and heart failure with preserved ejection fraction: Pathophysiology, quantification and treatment target

Ana Teresa Timóteo, Francisco Barbas Albuquerque, Bárbara Lacerda Teixeira

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)
35 Downloads (Pure)

Abstract

Heart failure is an important cause of mortality and morbidity worldwide. Heart failure with preserved ejection fraction (HFpEF) incidence and prevalence is increasing, and the phenotype associated with obesity is the most frequent. Epicardial adipose tissue (EAT) is directly associated with systemic obesity and several previous studies have shown a clear link between EAT and HFpEF. Moreover, the restriction induced by the pericardium is also linked to HFpEF. In this review we will describe the epidemiological association between the pericardium, EAT and HFpEF, how to quantify EAT, what are the pathophysiological mechanism to explain theses association and how can the pericardium and EAT be a treatment target in patients with HFpEF.

Original languageEnglish
Article number132303
JournalInternational Journal of Cardiology
Volume412
DOIs
Publication statusPublished - 1 Oct 2024

Keywords

  • Epicardial adipose tissue
  • Heart failure with preserved ejection fraction
  • Pericardium

Fingerprint

Dive into the research topics of 'Pericardium, epicardial adipose tissue, and heart failure with preserved ejection fraction: Pathophysiology, quantification and treatment target'. Together they form a unique fingerprint.

Cite this